{
  "cik": 1783183,
  "cik_padded": "0001783183",
  "entityName": "Phathom Pharmaceuticals, Inc.",
  "fiscal_years": [
    {
      "accn": "0001193125-26-073379",
      "filed": "2026-02-26",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "cost_of_revenue": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "gross_profit": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 229000.0,
        "cash": 129972000.0,
        "cost_of_revenue": 22599000.0,
        "eps_diluted": -3.03,
        "free_cash_flow": -167004000.0,
        "gross_profit": 152511000.0,
        "net_income": -221247000.0,
        "operating_cash_flow": -166775000.0,
        "operating_income": -159986000.0,
        "revenue": 175110000.0,
        "stockholders_equity": -438169000.0,
        "total_assets": 259149000.0,
        "total_liabilities": 697318000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "gross_margin": "ratio",
        "net_margin": "ratio",
        "operating_margin": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "gross_margin": 0.8709439780709268,
        "net_margin": -1.2634743875278396,
        "operating_margin": -0.9136314316715207,
        "revenue_growth_yoy": 2.169297039021212,
        "roa_avg2y": -0.6941441674627863,
        "roa_period_end": -0.8537443709989234,
        "roe_avg2y": 0.6396742170931942
      }
    },
    {
      "accn": "0001193125-26-073379",
      "filed": "2026-02-26",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "cost_of_revenue": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "gross_profit": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 135000.0,
        "cash": 297263000.0,
        "cost_of_revenue": 7973000.0,
        "eps_diluted": -5.29,
        "free_cash_flow": -266905000.0,
        "gross_profit": 47279000.0,
        "net_income": -334326000.0,
        "operating_cash_flow": -266770000.0,
        "operating_income": -277467000.0,
        "revenue": 55252000.0,
        "stockholders_equity": -253580000.0,
        "total_assets": 378318000.0,
        "total_liabilities": 631898000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "gross_margin": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "gross_margin": 0.8556975313110837,
        "revenue_growth_yoy": 80.01466275659824,
        "roa_avg2y": -0.8440870531205817,
        "roa_period_end": -0.8837168731067515,
        "roe_avg2y": 2.0489490989431234
      }
    },
    {
      "accn": "0001193125-26-073379",
      "filed": "2026-02-26",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "cost_of_revenue": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "gross_profit": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 1634000.0,
        "cash": 381393000.0,
        "cost_of_revenue": 167000.0,
        "eps_diluted": -3.93,
        "free_cash_flow": -139214000.0,
        "gross_profit": 515000.0,
        "net_income": -201592000.0,
        "operating_cash_flow": -137580000.0,
        "operating_income": -167312000.0,
        "revenue": 682000.0,
        "stockholders_equity": -72759000.0,
        "total_assets": 413842000.0,
        "total_liabilities": 486601000.0
      },
      "period_end": "2023-12-31",
      "ratio_units": {
        "gross_margin": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "gross_margin": 0.7551319648093842,
        "roa_avg2y": -0.6967642037010154,
        "roa_period_end": -0.487123104953098,
        "roe_avg2y": 2.7320986901397952
      }
    },
    {
      "accn": "0000950170-25-034183",
      "filed": "2025-03-06",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "gross_profit": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 1041000.0,
        "cash": 155385000.0,
        "eps_diluted": -5.05,
        "free_cash_flow": -147571000.0,
        "gross_profit": 0.0,
        "net_income": -197723000.0,
        "operating_cash_flow": -146530000.0,
        "operating_income": -172440000.0,
        "stockholders_equity": -74814000.0,
        "total_assets": 164810000.0,
        "total_liabilities": 239624000.0
      },
      "period_end": "2022-12-31",
      "ratio_units": {
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "roa_avg2y": -1.1163191160819894,
        "roa_period_end": -1.1997026879436927,
        "roe_avg2y": 148.7757712565839
      }
    },
    {
      "accn": "0000950170-24-073629",
      "filed": "2024-06-14",
      "fiscal_year": 2021,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 328000.0,
        "cash": 183259000.0,
        "eps_diluted": -3.89,
        "free_cash_flow": -148785000.0,
        "net_income": -143883000.0,
        "operating_cash_flow": -148457000.0,
        "operating_income": -135080000.0,
        "stockholders_equity": 72156000.0,
        "total_assets": 189431000.0,
        "total_liabilities": 117275000.0
      },
      "period_end": "2021-12-31",
      "ratio_units": {
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "roa_avg2y": -0.5938927894795497,
        "roa_period_end": -0.7595536105494877,
        "roe_avg2y": -1.0800932337938722
      }
    },
    {
      "accn": "0000950170-23-004875",
      "filed": "2023-02-28",
      "fiscal_year": 2020,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 1040000.0,
        "cash": 287496000.0,
        "free_cash_flow": -70728000.0,
        "net_income": -129068000.0,
        "operating_cash_flow": -69688000.0,
        "operating_income": -125665000.0,
        "stockholders_equity": 194271000.0,
        "total_assets": 295111000.0,
        "total_liabilities": 100840000.0
      },
      "period_end": "2020-12-31",
      "ratio_units": {
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "roa_avg2y": -0.4673929772275023,
        "roa_period_end": -0.4373540803290965,
        "roe_avg2y": -0.6113692666960349
      }
    },
    {
      "accn": "0000950170-22-002536",
      "filed": "2022-03-01",
      "fiscal_year": 2019,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 132000.0,
        "cash": 243765000.0,
        "free_cash_flow": -36642000.0,
        "net_income": -255131000.0,
        "operating_cash_flow": -36510000.0,
        "operating_income": -106215000.0,
        "stockholders_equity": 227955000.0,
        "total_assets": 257178000.0,
        "total_liabilities": 29223000.0
      },
      "period_end": "2019-12-31",
      "ratio_units": {
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "roa_avg2y": -1.9771466212027278,
        "roa_period_end": -0.9920405322383717,
        "roe_avg2y": -2.2511327089279964
      }
    },
    {
      "accn": "0001564590-21-016682",
      "filed": "2021-03-30",
      "fiscal_year": 2018,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 879000.0,
        "net_income": -1288000.0,
        "operating_cash_flow": -1023000.0,
        "operating_income": -1225000.0,
        "stockholders_equity": -1286000.0,
        "total_assets": 902000.0,
        "total_liabilities": 2188000.0
      },
      "period_end": "2018-12-31",
      "ratio_units": {
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "roa_period_end": -1.427937915742794,
        "roe_avg2y": 2.0031104199066876
      }
    },
    {
      "accn": "0001564590-20-011712",
      "filed": "2020-03-19",
      "fiscal_year": 2017,
      "form": "10-K",
      "fundamental_units": {
        "stockholders_equity": "USD"
      },
      "fundamentals": {
        "stockholders_equity": 0.0
      },
      "period_end": "2017-12-31",
      "ratios": {}
    }
  ],
  "latest_filing": {
    "accn": "0001193125-26-073379",
    "filed": "2026-02-26",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "2834",
  "sic_description": "Pharmaceutical Preparations",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001783183.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001783183.json"
  },
  "ticker": "PHAT"
}